Time to Response for Clinical and Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Tofacitinib, Adalimumab, or Placebo

Gladman, D, Coates, L, Wu, J et al. (6 more authors) (2019) Time to Response for Clinical and Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Tofacitinib, Adalimumab, or Placebo. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Metadata

Authors/Creators:
  • Gladman, D
  • Coates, L
  • Wu, J
  • Fallon, L
  • Hsu, M-A
  • Bushmakin, A
  • Bacci, E
  • Cappelleri, J
  • Helliwell, P
Keywords: patient-reported outcome measures and Health Assessment Questionnaire, Psoriatic arthritis
Dates:
  • Published: October 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 09 Nov 2020 14:43
Last Modified: 09 Nov 2020 16:11
Status: Published
Identification Number: https://doi.org/10.1002/art.41108
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)